Immunocore Holdings Ltd (IMCR)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.55B
Last updated: Nov 17, 2026 at 4:10 PM ET
Immunocore Holdings Ltd (IMCR) Statistics
Immunocore Holdings (IMCR) has a market cap of $1.55B. It has 51.56M shares outstanding.
Total Valuation
| Market Cap | $1.55B |
|---|---|
| Latest price (Nov 17, 2026) | $27.81 |
Key Dates
The next earnings report is expected on Feb 23, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 23, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 6, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 2.7x and 3.4x. Its year-end P/S ranged from 3.3x to 39.7x from 2021 to 2025.
| P/S Ratio | 2.7x |
|---|---|
| P/B Ratio | 3.4x |
Price Statistics
The stock is down 22.64% over 52 weeks and trades 9.62% below its 50-day average.
| Beta (1Y) | 0.65 |
|---|---|
| 52-Week Change | -22.64% |
| 1-Month Change | -6.80% |
| 3-Month Change | -24.55% |
| 6-Month Change | -3.87% |
| 5-Year Change | -20.85% |
| Total Return (1Y) | -22.64% |
| Total Return (3Y CAGR) | -16.01% |
| Total Return (5Y CAGR) | -6.26% |
| Return vs SPY (1Y) | -38.49% |
| Max Drawdown (1Y) | -30.90% |
| Max Drawdown (3Y) | -67.45% |
| Sharpe Ratio (1Y) | -0.84 |
| Correlation with SPY (1Y) | 0.24 |
| 50-Day Average | $30.77 |
| 200-Day Average | $31.54 |
| 52-Week Range | $27.50 to $40.71 |
| RSI (14 Days) | 37.6 |
| Average Volume (20 Days) | 501.08K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 4.62x current liabilities, and total debt is 0.94x shareholder equity.
| Current Ratio | 4.62x |
|---|---|
| Quick Ratio | 4.59x |
| Debt / Equity | 0.94x |
| Debt / EBITDA | 613.30x |
| Interest Coverage | -0.29x |
Returns and Efficiency
Return on invested capital is -0.51% over the last 12 months, against a 5-year average of -15.13%.
| Return on Assets (ROA) | -3.42% |
|---|---|
| Return on Invested Capital (ROIC) | -0.51% |
| ROIC (5Y Average) | -15.13% |
| Inventory Turnover | 0.71x |
| Receivables Turnover | 5.01x |
| Cash Conversion Cycle | -1036 days |
Scores
IMCR has an Altman Z-Score of 1.53, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 1.53 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Peer Position
Against 7 similar companies, IMCR has the 6th highest P/S.
P/S RatioPeer median 13.1x
ROICPeer median -59.97%
| P/S Ratio | 2.7x vs 13.1x median |
|---|---|
| ROIC | -0.51% vs -59.97% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About IMCR
What is IMCR's market cap?
Immunocore Holdings has a market cap of $1.55B.
How many shares of IMCR are outstanding?
Immunocore Holdings has 51.56M shares outstanding. The count is up 2.29% from a year earlier.
Does IMCR pay a dividend?
No. Immunocore Holdings does not pay a dividend.
IMCR pages: Overview, Charting, Statistics, Valuation, Competitors, Government Contracts